Indefinite Delivery Contract SPE2D222D0145
Award Date
8/26/22
Last Date to Order
8/25/27
Federal Agency
Medical Supply Chain
Awardee
Mylan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC, with a ceiling value of $8,346,790.65, is for the supply of clozapine tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a 5-year period from March 2023 to March 2026. The contract was competitively...
The Indefinite Delivery Contract (IDC) SPE2D222D0147 was awarded by the Defense Logistics Agency (DLA) to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC has a total ceiling value of $10,967,220.00 and a period of performance running through September 13, 2027. Under this contract, Mylan will provide the DLA, Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service with a variety of...
The Federal Supply Schedule contract awarded to Mylan Pharmaceuticals Inc. by the Department of Veterans Affairs National Acquisition Center (VA NAC) provides a range of pharmaceutical and hematology-related products to VA healthcare facilities, the Department of Defense, Bureau of Prisons, and Indian Health Service locations nationwide. The contract, valued at up to $364,546,690 over its 5-year period of performance, covers a diverse portfolio of drug products including specialty medications...
The federal contract IDV award is for the supply of Thioridazine HCl tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) through the VA's Pharmaceutical Prime Vendor program. The single-award indefinite delivery contract was issued by the VA National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, with a ceiling value of $267,666.40 and a period of...
Mylan Pharmaceuticals Inc. is providing pharmaceutical products to the Department of Veterans Affairs National Acquisition Center under a single-award Indefinite Delivery Contract. The contract has a potential value of $92.9 million and a period of performance through August 2024. Under the terms of the contract, Mylan will supply divalproex sodium tablets to meet the medication needs of veterans served by VA, DoD, Bureau of Prisons and Indian Health Service medical facilities nationwide. As the...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Mylan Pharmaceuticals Inc. to provide Carbidopa-Levodopa sustained-action (SA) tablets to the Department of Veterans Affairs (VA) National Acquisition Center. The contract has a 5-year period of performance from May 2020 to May 2025, with a ceiling value of $15,670,215.75. Under this IDC, Mylan will annually supply an estimated 50,537 bottles of 100mg Carbidopa-Levodopa SA tablets and 66,850 bottles of...
This federal contract IDV award is for the supply of Clonidine patches to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract was awarded by the VA National Acquisition Center on November 30, 2020 to DR Reddy's Laboratories, Inc., a multinational pharmaceutical manufacturer and supplier. The contract is a single-award Indefinite Delivery Contract (IDC) with a total ceiling value of $11,604,529.80 over a base...
The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contracted products include branded and...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $4,999,999.00, awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valid through December 2036, covers the procurement of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities...